Yang et al. proposed the conjugation of iron oxide (IO) nanoparticles to ATF for delivery of ATF-IO to uPAR-positive breast cancer cells, as they bind to tumor cells in vitro and localize in tumor site in vivo [149]. Here, PLAU is linked to breast cancer.